JB Chemicals and Pharmaceuticals Ltd to launch Molnupiravir 200 mg (Molunamax) for the Indian market

JB Chemicals and Pharmaceuticals Limited, one of the fastest growing pharmaceutical companies in India is set to launch Molnupiravir 200 mg for the Indian market. Marketed under the brand name Molunamax, it will soon be available all across the country in the next month for the treatment of mild COVID-19.

Recently Molnupiravir, received U.S. FDA, Emergency Use Authorization(EUA) for the Treatment of Mild to Moderate COVID-19. Molnupiravir should be administered as soon as possible after a diagnosis of COVID-19 has been made, and within five days of symptom onset. In India, the CDSCO has recently recommended for grant of permission to manufacture and market. Molnupiravir 200 mg capsule for restricted use under emergency situation in the country for treatment of patients above the age of 18 years, diagnosed COVID-19 positive, with SpO2 > 93% and those who have a high risk of progression of the disease. The recommended dose for Molnupiravir is 800 mg (four 200 mg capsules) taken orally every 12 hours for five days, with or without food. Completion of the full five-day treatment course is important to maximize viral clearance and may help in minimizing the transmission of SARS-CoV-2.

Commenting on the launch, Nikhil Chopra, CEO & Whole time Director mentioned "We are glad to launch Molnupiravir for the Indian market. At a time when India is threatened with the possibility of a third wave, the launch of this product will significantly help the country in its fight against COVID-19. We will work closely with the healthcare professionals, government and medical communities to ensure Molnupiravir's availability across the country so that no patient is left behind."

Shares of JB Chemicals & Pharmaceuticals Limited was last trading in BSE at Rs. 1643.75 as compared to the previous close of Rs. 1666.45. The total number of shares traded during the day was 3461 in over 713 trades.

The stock hit an intraday high of Rs. 1678.80 and intraday low of 1638.00. The net turnover during the day was Rs. 5740867.00.

Source : Equity Bulls

Keywords

JBChemicalsandPharmaceuticals INE572A01028 JBCHEPHARM Molnupiravir Molunamax Covid19Treatment